Polymorphic Light Eruption (PLE)
Also known as: Polymorphous light eruption / Polymorphic Light Eruption / Polymorphic light eruption (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00608 | Chloroquine | An antimalarial drug used to treat susceptible infections with P. vivax, P. malariae, P. ovale, and P. falciparum. It is also used for second line treatment for rheumatoid arthritis. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB04931 | Afamelanotide | 3 | Completed | 1 |
| DB00169 | Cholecalciferol | 3 | Terminated | 1 |
| DB13959 | Medium-chain triglycerides | 3 | Terminated | 1 |
| DB11094 | Vitamin D | 3 | Terminated | 1 |
| DB04931 | Afamelanotide | Not Available | Completed | 1 |
| DB02300 | Calcipotriol | Not Available | Completed | 1 |
| DB00169 | Cholecalciferol | Not Available | Completed | 1 |